Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan
· Delayed Price · Currency is TWD 67.50
-0.90 (-1.32%)
Jun 13, 2025, 2:31 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Neuromuscular System Medication | 136.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neuromuscular System Medication Growth | 16.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Formulations | 80.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Formulations Growth | 25.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-inflammatory, Analgesic and Anti-allergic | 72.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Anti-inflammatory, Analgesic and Anti-allergic Growth | 20.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gastrointestinal Tract Hepatobiliary System | 70.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gastrointestinal Tract Hepatobiliary System Growth | 24.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Drug | 69.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular Drug Growth | 33.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory Tract Medications | 49.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Respiratory Tract Medications Growth | 55.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endocrine System Medicine | 41.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Endocrine System Medicine Growth | 8.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Urinary System Medications | 34.54M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Urinary System Medications Growth | 17.83% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vitamins and Minerals | 30.26M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vitamins and Minerals Growth | 11.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 20.55M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 15.65% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chemotherapeutic Agents | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Taiwan | 605.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | 22.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 1.27M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 310.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|